Merck & Co., Inc. (NYSE:MRK)

CAPS Rating: 4 out of 5

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

Recs

1
Player Avatar pangordinah (< 20) Submitted: 9/1/2012 11:53:11 AM : Outperform Start Price: $41.54 MRK Score: -1.35

pharma, older population

Featured Broker Partners


Advertisement